455 related articles for article (PubMed ID: 29625129)
1. A negative feedback loop between microRNA-378 and Nrf1 promotes the development of hepatosteatosis in mice treated with a high fat diet.
Zhang T; Zhao X; Steer CJ; Yan G; Song G
Metabolism; 2018 Aug; 85():183-191. PubMed ID: 29625129
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
Wu H; Ng R; Chen X; Steer CJ; Song G
Gut; 2016 Nov; 65(11):1850-1860. PubMed ID: 26282675
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-206 prevents hepatosteatosis and hyperglycemia by facilitating insulin signaling and impairing lipogenesis.
Wu H; Zhang T; Pan F; Steer CJ; Li Z; Chen X; Song G
J Hepatol; 2017 Apr; 66(4):816-824. PubMed ID: 28025059
[TBL] [Abstract][Full Text] [Related]
4. LXRα Promotes Hepatosteatosis in Part Through Activation of MicroRNA-378 Transcription and Inhibition of Ppargc1β Expression.
Zhang T; Duan J; Zhang L; Li Z; Steer CJ; Yan G; Song G
Hepatology; 2019 Apr; 69(4):1488-1503. PubMed ID: 30281809
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-378 promotes hepatic inflammation and fibrosis via modulation of the NF-κB-TNFα pathway.
Zhang T; Hu J; Wang X; Zhao X; Li Z; Niu J; Steer CJ; Zheng G; Song G
J Hepatol; 2019 Jan; 70(1):87-96. PubMed ID: 30218679
[TBL] [Abstract][Full Text] [Related]
6. An Endoplasmic Reticulum Stress-MicroRNA-26a Feedback Circuit in NAFLD.
Xu H; Tian Y; Tang D; Zou S; Liu G; Song J; Zhang G; Du X; Huang W; He B; Lin W; Jin L; Huang W; Yang J; Fu X
Hepatology; 2021 Apr; 73(4):1327-1345. PubMed ID: 32567701
[TBL] [Abstract][Full Text] [Related]
7. Downregulated microRNA-130b-5p prevents lipid accumulation and insulin resistance in a murine model of nonalcoholic fatty liver disease.
Liu X; Chen S; Zhang L
Am J Physiol Endocrinol Metab; 2020 Jul; 319(1):E34-E42. PubMed ID: 32228319
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of microRNA-24 expression in liver prevents hepatic lipid accumulation and hyperlipidemia.
Ng R; Wu H; Xiao H; Chen X; Willenbring H; Steer CJ; Song G
Hepatology; 2014 Aug; 60(2):554-64. PubMed ID: 24677249
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1.
Hu Y; Ye H; Shi LX
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10072-10082. PubMed ID: 31799678
[TBL] [Abstract][Full Text] [Related]
12. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-376b-3p ameliorates nonalcoholic fatty liver disease by targeting FGFR1 and regulating lipid oxidation in hepatocytes.
Wang XY; Lu LJ; Li YM; Xu CF
Life Sci; 2022 Nov; 308():120925. PubMed ID: 36057399
[TBL] [Abstract][Full Text] [Related]
14. miR-188 promotes liver steatosis and insulin resistance via the autophagy pathway.
Liu Y; Zhou X; Xiao Y; Li C; Huang Y; Guo Q; Su T; Fu L; Luo L
J Endocrinol; 2020 Jun; 245(3):411-423. PubMed ID: 32252024
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of microRNA-367 promotes liver steatosis through repressing TBL1 in obese mice.
Li DD; Liu Y; Xue L; Su DY; Pang WY
Eur Rev Med Pharmacol Sci; 2017 Apr; 21(7):1598-1603. PubMed ID: 28429344
[TBL] [Abstract][Full Text] [Related]
16. MiR-150 deficiency ameliorated hepatosteatosis and insulin resistance in nonalcoholic fatty liver disease via targeting CASP8 and FADD-like apoptosis regulator.
Zhuge B; Li G
Biochem Biophys Res Commun; 2017 Dec; 494(3-4):687-692. PubMed ID: 29107687
[TBL] [Abstract][Full Text] [Related]
17. LncRNA-H19 promotes hepatic lipogenesis by directly regulating miR-130a/PPARγ axis in non-alcoholic fatty liver disease.
Liu J; Tang T; Wang GD; Liu B
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31064820
[No Abstract] [Full Text] [Related]
18. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.
Long JK; Dai W; Zheng YW; Zhao SP
Mol Med; 2019 Jun; 25(1):26. PubMed ID: 31195981
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-122 Inhibits Lipid Droplet Formation and Hepatic Triglyceride Accumulation via Yin Yang 1.
Wu GY; Rui C; Chen JQ; Sho E; Zhan SS; Yuan XW; Ding YT
Cell Physiol Biochem; 2017; 44(4):1651-1664. PubMed ID: 29216638
[TBL] [Abstract][Full Text] [Related]
20. A novel role of CRTC2 in promoting nonalcoholic fatty liver disease.
Han HS; Kim SG; Kim YS; Jang SH; Kwon Y; Choi D; Huh T; Moon E; Ahn E; Seong JK; Kweon HS; Hwang GS; Lee DH; Cho KW; Koo SH
Mol Metab; 2022 Jan; 55():101402. PubMed ID: 34838715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
